Jefferies Maintained a Buy Rating on UnitedHealth (UNH), Keeps the PT Unchanged

UnitedHealth Group Incorporated (NYSE:UNH) is one of the 10 Cheapest High-Quality Stocks to Buy According to Hedge Funds. On June 11, Jefferies analyst David Windley maintained a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH), with a price target of $399.

The rating comes after the company announced increased quarterly dividends. UnitedHealth Group Incorporated (NYSE:UNH) increased the quarterly dividend from $2.10 to $2.21 per share. The company’s annual dividends now stand at $8.84 per share reflecting a yield of 2.9%.

In addition, the company posted growth in its fiscal first quarter of 2025. Revenues for the quarter reached $109.6 billion, representing a $9.8 billion increase compared to the same period last year. The number of consumers served by UnitedHealthcare increased by 780,000 year-to-date, whereas Optum Health expects to serve 650,000 new value-based care patients in 2025.

UnitedHealth Group Incorporated (NYSE:UNH) is a healthcare company that works in two areas including health insurance and health services. The company helps people get medical care and insurance while using technology to make better healthcare services.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.